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Introduction
We have previously found specific genes upregulated in
PBMCs of active sJIA [1]. Biologics to block IL-1 and IL-6
signalling have both been shown to be effective in early
clinical trials. In this study we examine the expression
before and after anti-IL1 and anti IL-6R treatment in
PBMCs and their constitutive cell types; using gene expres-
sion analysis to further understand the disease pathways.
Methods
PBMCs were collected before and after treatment from
patients that responded to treatment: two patients were
treated with tocilizumab, one with anakinra and another
with an experimental anti-IL1 antibody (Novartis). A pro-
portion of PBMCs were reserved and positive selection of
B cells, T cells and monocytes performed on the rest. RNA
was extracted and hybridised to Affymetrix U133 Plus 2.0
arrays. Paired significance analysis was performed using
LIMMA.
Results
In the B cell population we found 1902 genes differen-
tially expressed after anti-IL1 treatment and 165 after anti-
IL6R treatment. While genes involved in transcriptional
regulation and the immune response were differentially
expressed after both treatments there were only 24 genes
that were common to both lists including TCL1A and
CD69. Differential expression unique to the anti-IL1
blockade included downregulation of complement-medi-
ated immunity genes e.g. CD55. Other genes downregu-
lated after anti-IL1 include IL12RB2, and CREB1. Genes
upregulated after anti-IL6R treatment include CEBPδ and
BTLA. We are currently characterising gene expression in
the remaining cell types.
Conclusion
We have found that the majority of changes in gene
expression in B cells differ according to the specific
cytokine modulation.
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